McClure Natalie

SVP, Product Development at Adamas Pharmaceuticals Inc

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
9
Latest Apr 18, 2016
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Dec 5, 2014 2014

    Sold 2,000 shares at $14.01 ($28k)

    McClure Natalie, SVP, Product Development

    Sold 70.4% of holdings ($40k position)840 shares leftFiling

  2. 2 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Jan 5, 2015 +31 days

    Sold 2,000 shares at $17.59 ($35k)

    McClure Natalie, SVP, Product Development

    Sold 70.4% of holdings ($50k position)840 shares leftFiling

  3. 3 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Feb 5, 2015 +31 days

    Sold 2,000 shares at $16.87 ($34k)

    McClure Natalie, SVP, Product Development

    Sold 70.4% of holdings ($48k position)840 shares left1x usual sizeFiling

  4. 4 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Mar 5, 2015 +28 days

    Sold 2,000 shares at $17.15 ($34k)

    McClure Natalie, SVP, Product Development

    Sold 70.4% of holdings ($49k position)840 shares left1x usual sizeFiling

  5. 5 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Apr 6, 2015 +32 days

    Sold 2,000 shares at $17.44 ($35k)

    McClure Natalie, SVP, Product Development

    Sold 70.4% of holdings ($50k position)840 shares left1x usual sizeFiling

  6. 6 Form 4 sale Adamas Pharmaceuticals IncUnusual
    May 5, 2015 +29 days

    Sold 2,000 shares at $17.62 ($35k)

    McClure Natalie, SVP, Product Development

    Sold 70.4% of holdings ($50k position)840 shares left1x usual sizeFiling

  7. 7 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Jun 5, 2015 +31 days

    Sold 2,000 shares at $18.95 ($38k)

    McClure Natalie, SVP, Product Development

    Sold 70.4% of holdings ($54k position)840 shares left1x usual sizeFiling

  8. 8 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Apr 18, 2016 +318 days

    Sold 36,000 shares at $18.50 ($666k)

    McClure Natalie, SVP, Product Development

    Sold 81.2% of holdings ($820k position)8,340 shares left18x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by McClure Natalie
Source
Apr 18, 2016Apr 20, 2016Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale36,000$666k81.2%UnusualSEC
Jun 5, 2015Jun 9, 2015Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale2,000$38k70.4%UnusualSEC
May 5, 2015May 7, 2015Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale2,000$35k70.4%UnusualSEC
Apr 6, 2015Apr 7, 2015Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale2,000$35k70.4%UnusualSEC
Mar 5, 2015Mar 9, 2015Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale2,000$34k70.4%UnusualSEC
Feb 5, 2015Feb 6, 2015Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale2,000$34k70.4%UnusualSEC
Jan 5, 2015Jan 7, 2015Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale2,000$35k70.4%UnusualSEC
Dec 5, 2014Dec 9, 2014Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale2,000$28k70.4%UnusualSEC
Dec 1, 2014Dec 3, 2014Adamas Pharmaceuticals IncSVP, Product DevelopmentForm 4 sale20,000$290k96.0%UnusualSEC